TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Ryan Douglas
Exagen Inc. to Participate in Fourth Quarter Investor Conferences

Exagen Inc., a leading autoimmune diagnostics company, announced participation in two upcoming investor conferences in November 2025, highlighting its commitment to showcasing its innovative autoimmune testing solutions.

Insights
META   neutral

Part of tech companies planning significant capital expenditure in data centers for AI infrastructure


XGN   positive

The company is actively engaging with investors, presenting at multiple conferences, and demonstrating confidence in its market position and diagnostic technologies